Chronic Kidney Disease

Data from Italy indicate the impact of COVID-19 is not greater for children with chronic kidney disease or immunosuppression compared with a pediatric cohort who have neither condition.

CV outcomes of finerenone (Bayer) vs. placebo in patients with type 2 diabetes and chronic kidney disease.

Patients who received 3 months of individualized nutritional counseling reaped a variety of benefits, including better adherence to dietary recommendations, decreased BMI and improved kidney function.

A survey of patients with chronic kidney disease determined that although many are interested in using mobile health technologies, current electronic health literacy and use of these apps were low.

Researchers from Spain found that for patients with chronic kidney disease, serum magnesium levels increased as kidney function declined and that individuals with hypermagnesemia had an elevated risk for cardiovascular events and mortality.

The benefits of dapagliflozin remain consistent in patients with chronic kidney disease, with and without type 2 diabetes, independent of baseline CV status, according to an analysis of the DAPA-CKD trial.

Researchers from Canada observed no link between higher doses of sitagliptin and increased risk for congestive heart failure in a cohort of patients older than 66 years who had both type 2 diabetes and chronic kidney disease.

Patients with chronic kidney disease who were initiated on renin-angiotensin system inhibitors experienced greater benefits, including a reduced need for dialysis, than those initiated on calcium channel blockers.

A study of patients with chronic kidney disease showed no direct relationship between lower eGFR levels and metabolic rate, leading researchers to suggest other factors may play a bigger role in differences in energy metabolism.

Despite finding patients and providers have “positive perceptions” of nutrition therapy in chronic kidney disease, researchers suggest the broad implementation of such programs may be limited due to cost-related factors.